GlassScriptPhysician profile
Dylan Jacob Lewis
NPI 1346701349
$3,952.41
in general payments reported to CMS, 2019-2025
16 companies · $732 in 2025
The $732 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.97 · 2022: $162 · 2023: $1,496 · 2024: $1,512 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,082 · Travel and Lodging: $606 · Grant: $52.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,082.27 |
| Travel and Lodging | $605.56 |
| Grant | $52.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,575.19 | 2022-2024 | Vanta Adaptivestim, Synchromedii, Intellis Adaptivestim |
| Boston Scientific Corporation | $727.71 | 2023-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product |
| Abbott Laboratories | $511.97 | 2024 | Proclaim, Eterna, Octrode |
| Si-Bone, INC. | $361.56 | 2023-2025 | |
| Spr Therapeutics, INC | $149.57 | 2025 | Sprint Pns System |
| Curonix LLC | $126.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $103.71 | 2025 | Senza |
| Abbvie INC. | $93.22 | 2024 | |
| Nevro Corp. | $73.21 | 2024 | Senza |
| Saluda Medical Americas, INC. | $72.08 | 2024-2025 | Evoke |
| Stryker Corporation | $51.32 | 2025 | Optablate, Spinejack |
| Merz North America, INC. | $34.78 | 2021 | |
| Collegium Pharmaceutical, INC. | $22.22 | 2024 | Xtampza |
| Merck Sharp & Dohme LLC | $17.16 | 2024 | Bridion |
| Foundation Fusion Solutions, LLC | $16.94 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $15.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.